Abiopharma

New Form 8-K - Cingulate Inc. Filed: 2025-07-22 AccNo: 0001641172-25-020618 Size: 841 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits